Roche's new oncology drugs to add $5B in sales by 2021
Roche Holding can add $5 billion in new oncology drug revenue between 2018-21. Roche will soon face competition for its older oncology drugs with potential losses calculated at $3 billion. However, Roche will likely be able to more than offset these declines over the next three years, primarily with its relatively newer drugs.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063